Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3872707

O=C(O)C(F)(F)F.c1c2c(cc(N3CCOCC3)c1C1CC1)CNC2

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
CNR2 P34972 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 4/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
KDM4E B2RXH2 3/20 0.34
SLC13A5 Q86YT5 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CASP1 P29466 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8262268 0.87 CNR2 (0.39) CNR2ALDH1A1HPGDTSHRMAPK1
Trifluoroacetic Acid SCHEMBL3883074 0.83 KDM1A (0.34)
Trifluoroacetic Acid SCHEMBL3877058 0.83 ALDH1A1 (0.48) L3MBTL1ALDH1A1HPGDNPC1TP53
Trifluoroacetic Acid SCHEMBL3876344 0.77 KDM1A (0.34)
SCHEMBL3872709 0.76 ALDH1A1 (0.35) CNR2ALDH1A1HPGDTP53SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3878343 0.75 RAF1 (0.36) CNR2
SCHEMBL8263179 0.71 NOTUM (0.44) ALDH1A1TP53SMN1; SMN2PIK3CAMTOR
SCHEMBL3880562 0.71 USP2 (0.48) SMN1; SMN2PIK3CAMTORKDM4E
Trifluoroacetic Acid SCHEMBL3871426 0.70 PRKAB2 (0.36)
Hydrochloric Acid SCHEMBL3874281 0.70 NOTUM (0.43) ALDH1A1TP53SMN1; SMN2PIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188139-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
EP-1848694-B1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 HOFFMANN LA ROCHE (CH) 2009-11-25 EP disclosed
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES JOLIDON SYNESE 2009-08-13 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
EP-1848694-A1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 F. Hoffmann-Roche AG (CH) 2007-10-31 EP disclosed
WO-2006082001-A1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 F.HOFFMANN-LA ROCHE AG (CH) 2006-08-10 WO disclosed
US-20060178381-A1 Heterocyclic-substituted phenyl methanones HOFFMANN-LA ROCHE INC. 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES CYP2B6, CYP2D6, CYP1A2 L3MBTL1 4593/4885CNR2 414/4885ALDH1A1 52/4885
US-20060178381-A1 Heterocyclic-substituted phenyl methanones CYP2B6, CYP2D6, CYP1A2 L3MBTL1 4593/4885CNR2 414/4885ALDH1A1 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.